financetom
Business
financetom
/
Business
/
Masimo sues US Customs over approval of Apple Watch imports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo sues US Customs over approval of Apple Watch imports
Aug 20, 2025 3:57 PM

WASHINGTON, Aug 20 (Reuters) - Medical monitoring

technology company Masimo ( MASI ) sued U.S. Customs and Border

Protection on Wednesday over a decision by the agency that

allowed Apple ( AAPL ) to import Apple Watches with blood-oxygen

reading technology during a patent dispute between the

companies.

Masimo ( MASI ) said in the lawsuit in Washington, D.C., federal

court that Customs improperly determined that Apple ( AAPL ) can import

watches with pulse oximetry technology, reversing its

own decision from last year without notifying Masimo ( MASI ).

Masimo ( MASI ) told the court that it learned of the agency's August

1 decision only after Apple ( AAPL ) announced it would reintroduce

blood-oxygen reading to its watches last week.

Spokespeople for Apple ( AAPL ) and Customs did not immediately respond

to requests for comment. A Masimo ( MASI ) spokesperson declined to

comment.

Irvine, California-based Masimo ( MASI ) has accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology to

use in its Apple Watches. Masimo ( MASI ) has separately sued Apple ( AAPL ) for

patent infringement and trade secret theft in ongoing federal

court cases.

Masimo ( MASI ) convinced the U.S. International Trade Commission to

block imports of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches in

2023 based on a determination that Apple's ( AAPL ) technology for

reading blood oxygen levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has continued to sell Customs-approved redesigned

watches without pulse oximetry since the ITC's decision.

Apple ( AAPL ) said on Aug. 14 that it would reintroduce its

smartwatches' blood-oxygen reading capabilities with approval

from Customs. Masimo ( MASI ) said the agency's decision to approve the

watches without input from Masimo ( MASI ) or any "meaningful

justification" deprived the company of its rights.

"CBP's function is to enforce ITC exclusion orders, not to

create loopholes that render them ineffective," Masimo ( MASI ) said.

Masimo ( MASI ) asked the Washington court to halt the agency's

ruling and continue to block Apple ( AAPL ) from selling watches with the

blood-oxygen feature.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Graco Q3 Adjusted Earnings, Net Sales Rise
Graco Q3 Adjusted Earnings, Net Sales Rise
Oct 22, 2025
04:26 PM EDT, 10/22/2025 (MT Newswires) -- Graco ( GGG ) reported Q3 adjusted earnings late Wednesday of $0.73 per diluted share, up from $0.71 a year earlier. Analysts polled by FactSet expected $0.74. Net sales for the quarter ended Sept. 26 rose to $543.4 million from $519.2 million a year earlier. Analysts surveyed by FactSet expected $562.1 million. ...
Banc of California's Q3 EPS jumps as NII grows
Banc of California's Q3 EPS jumps as NII grows
Oct 22, 2025
Overview * Banc of California ( BANC ) Q3 diluted EPS rises to $0.38 from $0.12 in Q2 * Total revenue for Q3 grows over 5% driven by net interest income growth * Company repurchased 2.2 mln shares at $16.48 per share in Q3 Outlook * Company expects further earnings growth as it continues to remix the balance sheet *...
Churchill Downs Q3 Adjusted EPS, Revenue Rise
Churchill Downs Q3 Adjusted EPS, Revenue Rise
Oct 22, 2025
04:26 PM EDT, 10/22/2025 (MT Newswires) -- Churchill Downs (CHDN) reported Q3 adjusted earnings late Wednesday of $1.09 per diluted share, up from $0.97 a year ago. Analysts polled by FactSet expected $0.98. Net revenue for the quarter ended Sept. 30 was $683.0 million, up from $628.5 million a year earlier. Analysts surveyed by FactSet expected $672.2 million. The firm...
Reliance Q3 Adjusted Earnings Unchanged, Net Sales Rise; Q4 EPS Guidance Set
Reliance Q3 Adjusted Earnings Unchanged, Net Sales Rise; Q4 EPS Guidance Set
Oct 22, 2025
04:26 PM EDT, 10/22/2025 (MT Newswires) -- Reliance (RS) reported Q3 adjusted earnings late Wednesday of $3.64 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected $3.68. Net sales for the quarter ended Sept. 30 was $3.65 billion, up from $3.42 billion a year earlier. Analysts surveyed by FactSet expected $3.54 billion. The company set Q4...
Copyright 2023-2026 - www.financetom.com All Rights Reserved